International pharmacy survey of peripheral vasopressor infusions in critical care (INFUSE)

Sardaneh, Arwa Abu; Penm, Jonathan; Oliver, Matthew; Gattas, David; McLachlan, Andrew J.; James, Christie; Cella, Christina; Aljuhani, Ohoud; Acquisto, Nicole M.; Patanwala, Asad E.

doi:10.1016/j.jcrc.2023.154376

Cited by 6 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies examining vasopressor dose trajectories and implementation of peripheral vasopressor delivery protocols have shown that approximately 50% of patients requiring vasopressors can avoid need for CVC, with extravasation of peripheral vasopressors being uncommon, and tissue injury being very rare with monitored peripheral administration . A recent international survey of ICUs in the US, Australia, the UK, Canada, and Saudi Arabia found that norepinephrine was delivered peripherally in 113 of 132 centers (86%), reducing need for CVCs …”

Section: Discussionmentioning

confidence: 99%

Complication Rates of Central Venous Catheters

Teja,

Bosch,

Diep

et al. 2024

JAMA Intern Med

View full text Add to dashboard Cite

ImportanceCentral venous catheters (CVCs) are commonly used but are associated with complications. Quantifying complication rates is essential for guiding CVC utilization decisions.ObjectiveTo summarize current rates of CVC-associated complications.Data SourcesMEDLINE, Embase, CINAHL, and CENTRAL databases were searched for observational studies and randomized clinical trials published between 2015 to 2023.Study SelectionThis study included English-language observational studies and randomized clinical trials of adult patients that reported complication rates of short-term centrally inserted CVCs and data for 1 or more outcomes of interest. Studies that evaluated long-term intravascular devices, focused on dialysis catheters not typically used for medication administration, or studied catheters placed by radiologists were excluded.Data Extraction and SynthesisTwo reviewers independently extracted data and assessed risk of bias. Bayesian random-effects meta-analysis was applied to summarize event rates. Rates of placement complications (events/1000 catheters with 95% credible interval [CrI]) and use complications (events/1000 catheter-days with 95% CrI) were estimated.Main Outcomes and MeasuresTen prespecified complications associated with CVC placement (placement failure, arterial puncture, arterial cannulation, pneumothorax, bleeding events requiring action, nerve injury, arteriovenous fistula, cardiac tamponade, arrhythmia, and delay of ≥1 hour in vasopressor administration) and 5 prespecified complications associated with CVC use (malfunction, infection, deep vein thrombosis [DVT], thrombophlebitis, and venous stenosis) were assessed. The composite of 4 serious complications (arterial cannulation, pneumothorax, infection, or DVT) after CVC exposure for 3 days was also assessed.ResultsOf 11 722 screened studies, 130 were included in the analyses. Seven of 15 prespecified complications were meta-analyzed. Placement failure occurred at 20.4 (95% CrI, 10.9-34.4) events per 1000 catheters placed. Other rates of CVC placement complications (per 1000 catheters) were arterial canulation (2.8; 95% CrI, 0.1-10), arterial puncture (16.2; 95% CrI, 11.5-22), and pneumothorax (4.4; 95% CrI, 2.7-6.5). Rates of CVC use complications (per 1000 catheter-days) were malfunction (5.5; 95% CrI, 0.6-38), infection (4.8; 95% CrI, 3.4-6.6), and DVT (2.7; 95% CrI, 1.0-6.2). It was estimated that 30.2 (95% CrI, 21.8-43.0) in 1000 patients with a CVC for 3 days would develop 1 or more serious complication (arterial cannulation, pneumothorax, infection, or DVT). Use of ultrasonography was associated with lower rates of arterial puncture (risk ratio [RR], 0.20; 95% CrI, 0.09-0.44; 13.5 events vs 68.8 events/1000 catheters) and pneumothorax (RR, 0.25; 95% CrI, 0.08-0.80; 2.4 events vs 9.9 events/1000 catheters).Conclusions and RelevanceApproximately 3% of CVC placements were associated with major complications. Use of ultrasonography guidance may reduce specific risks including arterial puncture and pneumothorax.

show abstract

Section: Discussionmentioning

confidence: 99%